Skip to content
Trial Eligibility
Menu

Lung Cancer Clinical Trials near Tampa, FL

108 studies for Lung Cancer are recruiting at 169 sites within 50 miles of Tampa, Florida, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Lung Cancer trials in the US or all trials near Tampa.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Lung Cancer studies enrolling near Tampa

Showing the 50 nearest of 108 studies.
  1. Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

    NCT06498635

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Moffitt Cancer Center (Tampa, FL); Moffitt Cancer Center - McKinley Campus (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    8 sites within 50 mi
  2. Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

    NCT07222566

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Florida Cancer Specialists (Tampa, FL); Florida Cancer Specialists (St. Petersburg, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    8 sites within 50 mi
  3. Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

    NCT05334069

    • Observational
    • Ages 40 to 75 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest sites: Saint Joseph's Hospital/Children's Hospital-Tampa (Tampa, FL); Mease Countryside Hospital (Safety Harbor, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  4. Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

    NCT06096844

    • Phase 3
    • Ages 70 years and older
    • Sex: All

    Nearest sites: James A. Haley Veterans Affairs Hospital (Tampa, FL); Moffitt Cancer Center (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    6 sites within 50 mi
  5. Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

    NCT06418204

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Saint Joseph's Hospital/Children's Hospital-Tampa (Tampa, FL); Saint Anthony's Hospital Cancer Care Center (St. Petersburg, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    5 sites within 50 mi
  6. Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

    NCT03851445

    • Phase 2/3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Moffitt Cancer Center (Tampa, FL); Moffitt Cancer Center - McKinley Campus (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  7. Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

    NCT05624996

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Saint Joseph's Hospital/Children's Hospital-Tampa (Tampa, FL); Morton Plant Hospital (Clearwater, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  8. Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation

    NCT07012031

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Moffitt Cancer Center (Tampa, FL); Moffitt Cancer Center - McKinley Campus (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  9. A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

    NCT06875310

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: H. Lee Moffitt Cancer Center & Research Institute (Tampa, FL); St. Anthony's Hospital (St. Petersburg, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  10. Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

    NCT06890598

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Moffitt Cancer Center (Tampa, FL); Comprehensive Hematology Oncology (St. Petersburg, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  11. A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)

    NCT07218146

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Moffitt Cancer Center (Tampa, FL); Florida Cancer Specialists - North (St. Petersburg, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  12. Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

    NCT04267848

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Moffitt Cancer Center (Tampa, FL); Moffitt Cancer Center at SouthShore (Ruskin, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  13. Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

    NCT04613596

    • Phase 2/3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: James A. Haley Veterans Hospital (Tampa, FL); Bay Pines Veterans Affairs Healthcare System (Bay Pines, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  14. Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

    NCT06040541

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Lee Moffitt Cancer Center (Tampa, FL); Florida Cancer Specialists (Sarasota, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  15. Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

    NCT06128551

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Moffitt Cancer Center and Research Institute (Tampa, FL); Florida Cancer Specialists (Sarasota, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  16. A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

    NCT06667076

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Moffitt Cancer Center (Tampa, FL); Florida Cancer Specialists & Research Institute 1 (St. Petersburg, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  17. A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

    NCT06983743

    • Phase 1
    • Ages 18 to 99 years
    • Sex: All

    Nearest sites: Moffitt Cancer Center (Tampa, FL); Florida Cancer Specalists (Sarasota, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  18. AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

    NCT07038343

    • Phase 1/2
    • Ages 18 to 75 years
    • Sex: All

    Nearest sites: Avenzo Therapeutics Recruiting Site (Tampa, FL); Avenzo Therapeutics Recruiting Site (Sarasota, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  19. A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

    NCT07070232

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Moffitt Cancer Center (Tampa, FL); Florida Cancer Specialists (Sarasota, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  20. Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.

    NCT07168993

    • Interventional
    • Ages 50 to 80 years
    • Sex: All

    Nearest sites: James A. Haley Veterans' Hospital (Tampa, FL); Bay Pines VA Healthcare System (Bay Pines, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  21. Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

    NCT07291037

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Research Site (Tampa, FL); Research Site (St. Petersburg, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  22. A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

    NCT07458347

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Moffitt Cancer Center (Tampa, FL); Florida Cancer Specialists (Sarasota, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  23. A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

    NCT07629960

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Moffitt Cancer Center (Tampa, FL); Florida Cancer Specialists & Research Institute - Sarasota (Sarasota, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  24. SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

    NCT03452774

    • Observational
    • Ages Any age
    • Sex: All

    Nearest site: Massive Bio SYNERGY-AI site (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  25. A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types

    NCT04300556

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Moffitt Cancer Center and Research Institute (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  26. A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)

    NCT04302025

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Moffitt Cancer Center (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  27. Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm

    NCT04317534

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Moffit Cancer Center (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  28. Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers

    NCT04410796

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Moffitt Cancer Center (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  29. Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

    NCT04614103

    • Phase 2
    • Ages 18 to 70 years
    • Sex: All

    Nearest site: H Lee Moffitt Cancer Center and Research Institute (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  30. Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067

    NCT04787042

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Moffitt Cancer Center (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  31. Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

    NCT04981119

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest site: Moffitt Cancer Center (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  32. MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors

    NCT05076760

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Moffitt Cancer Center (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  33. Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

    NCT05176483

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Exelixis Clinical Site #8 (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  34. Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets

    NCT05317858

    • Phase 3
    • Ages 18 to 100 years
    • Sex: All

    Nearest site: Moffitt Cancer Center (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  35. A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

    NCT05361174

    • Phase 1/2
    • Ages 18 to 70 years
    • Sex: All

    Nearest site: Moffitt Cancer Center (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  36. Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

    NCT05379985

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Moffitt Cancer Center (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  37. Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

    NCT05642572

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Moffitt Cancer Center (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  38. Clinical Trial of CD40L-Augmented TIL for Patients With EGFR, ALK, ROS1 or HER2-Driven NSCLC

    NCT05681780

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Moffitt Cancer Center (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  39. DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers

    NCT05882058

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: H. Lee Moffitt Cancer Center and Research Institute (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  40. A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC

    NCT06010329

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Moffitt Cancer Center (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  41. Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

    NCT06031688

    • Phase 2
    • Ages 18 Minutes and older
    • Sex: All

    Nearest site: Moffitt Cancer Center (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  42. A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

    NCT06051695

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Moffitt Cancer Center (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  43. A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer

    NCT06095505

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Moffitt Cancer Center (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  44. Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

    NCT06162221

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: H Lee Moffitt Cancer Center and Research Institute (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  45. Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers

    NCT06196008

    • Interventional
    • Ages 18 years and older
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: Moffitt Cancer Center (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  46. LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

    NCT06216301

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Moffitt Cancer Center (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  47. A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors

    NCT06326411

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Moffitt Cancer Center (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  48. A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)

    NCT06362252

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Moffitt Cancer Center (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  49. Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

    NCT06616584

    • Phase 2/3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Moffitt Cancer Center (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  50. Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

    NCT06625775

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Moffitt Cancer Center (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Lung Cancer clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.